RFK Jr. Says Antidepressants Are Dangerous. Here’s What Mental Health Experts Say

Public health debates are supposed to be about evidence. Lately, though, they’ve started to sound a little like social media comment sections with better lighting. When Robert F. Kennedy Jr. suggested antidepressants might be contributing to violence, the claim spread quicklybecause of course it did. It’s dramatic, it’s scary, and it hits a nerve in a country already struggling with trust, mental health access, and headline fatigue.

But mental health experts, psychiatrists, and federal health agencies are pushing back on one big point: the evidence does not support a direct causal claim that antidepressants (including SSRIs) cause mass violence. That doesn’t mean antidepressants are risk-free. They are not. Like all medications, they come with side effects, warnings, and important monitoring guidelinesespecially for children, teens, and young adults.

The real story is less viral and more useful: antidepressants can help many people, they can harm some people, and they should be prescribed and monitored carefully. In other words, the truth is nuanced. (Yes, nuancethe least clickable word on the internet.)

What RFK Jr. Saidand Why Experts Objected

RFK Jr. has repeatedly raised the idea that SSRIs and other psychiatric medications may be linked to violence, including mass shootings. In several reports and interviews, he also referenced black box warnings in a way that many experts said was misleading.

Mental health experts object for two reasons:

• There is no established direct causal evidence showing SSRIs cause mass shootings or mass violence.
• The black box warning is about suicidality risk in younger patientsnot “homicidal ideation.”

This distinction matters. When a public figure compresses a complicated safety warning into a viral talking point, patients may panic, families may get confused, and people who need treatment may delay care. That’s not a theoretical concern; it happens in clinics all the time after scary headlines.

What Antidepressants Actually Are

Antidepressants are medications commonly used to treat depression, and they’re also prescribed for other conditions, including anxiety disorders, panic disorder, and in some cases pain or insomnia. SSRIs (selective serotonin reuptake inhibitors) are one of the most commonly prescribed categories.

Common SSRI examples include:

• Sertraline (Zoloft)
• Fluoxetine (Prozac)
• Escitalopram (Lexapro)
• Citalopram (Celexa)
• Paroxetine (Paxil)

These medications are not “happy pills,” and they’re not a magic switch. Antidepressants can take several weeks to work. In many cases, sleep, appetite, and concentration improve before mood does. That delay can be frustrating, which is exactly why medical follow-up matters in the early phase of treatment.

Do Antidepressants Cause Violence?

The short answer: experts say the evidence does not prove that

Fact-checkers, psychiatrists, and major news outlets reviewing available evidence have reached a similar conclusion: current data do not prove that SSRIs cause mass violence. Some studies explore associations between medication use and behavior in certain populations, but association is not the same thing as causation. Mental health experts emphasize that violent behavior is complex and typically involves multiple factors, not a single medication variable.

That complexity gets lost online. It’s easier to blame one class of drugs than to talk about social isolation, trauma, access to firearms, untreated mental illness, substance use, or warning signs that go unaddressed. Unfortunately, easier is not the same as accurate.

Why this claim spreads anyway

Three reasons:

1. Fear is sticky. A frightening claim spreads faster than a clinical explanation.
2. SSRIs are common. Millions of Americans use them, so they often show up in broad conversations about mental health.
3. Medication warnings are real. Because SSRIs do carry serious warnings, it’s easy for people to overgeneralize what those warnings mean.

In plain English: a medication can have real risks and still not be the cause of a specific social crisis.

What the Black Box Warning Actually Says

This is the part that gets misquoted a lot.

FDA labeling and federal drug information warn about an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults during early treatment (especially in the first few months) and around dose changes. The warning does not state that SSRIs cause homicidal ideation.

Important context:

• The warning is strongest for younger patients (including many under age 25).
• Patients should be closely monitored early in treatment and after dose changes.
• Depression itself also raises the risk of suicidal thoughts and behaviors.
• Stopping medication suddenly can cause withdrawal-like symptoms and clinical worsening.

This is why clinicians don’t use a “take this and good luck” approach. They typically recommend follow-up, symptom tracking, and clear instructions for what changes to watch for. That’s not alarmist; it’s good medicine.

Yes, Antidepressants Have Risks. No, That Doesn’t Make Them “Bad.”

Let’s say it clearly: antidepressants are not harmless. They can cause side effects, and for some people, the first medication tried is not the right one. Common side effects with SSRIs may include nausea, sleep problems, agitation, sweating, fatigue, dizziness, and sexual side effects. Some patients may also experience increased restlessness or emotional blunting.

But risk alone is not a reason to dismiss a treatment. Every medical decision is a trade-off: the risk of treatment versus the risk of the untreated condition.

Untreated depression can disrupt work, school, relationships, sleep, appetite, and daily functioning. In some cases, it can become life-threatening. That’s why major health organizations consistently present antidepressants as one evidence-based treatment optionoften alongside psychotherapy, and sometimes in combination when symptoms are moderate to severe.

What experts typically recommend instead of panic

• Shared decision-making: patients and clinicians choose treatment together.
• Start low, monitor closely: especially in younger patients.
• Use therapy when appropriate: CBT and other evidence-based therapies can be highly effective.
• Combine treatments when needed: medication + therapy often works better for more severe depression.
• Do not stop abruptly: tapering should be supervised.

That approach is less dramatic than a viral rant, but it’s also more likely to help a real human being on a real Tuesday.

Why “Don’t Stop Suddenly” Is Such a Big Deal

One of the most dangerous effects of misinformation is what happens after people read it. A patient sees a scary post, gets spooked, and quits medication cold turkey. That can backfire.

Medical sources consistently warn that suddenly stopping SSRIs can trigger withdrawal-like symptoms (often called discontinuation syndrome), including anxiety, dizziness, nausea, insomnia, flu-like symptoms, and “electric shock” sensations. Symptoms can be miserable, and they may also be confused with a relapse of depression or anxiety.

This is a big reason mental health experts dislike broad public claims that paint antidepressants as universally dangerous. The message many patients hear isn’t “ask better questions”it’s “throw the bottle away.” Those are not the same thing.

What Mental Health Experts Want the Public to Understand

1) Medication decisions are individualized

No psychiatrist worth their license believes every patient should be on an SSRI. But no serious expert believes every patient should avoid them either. The right treatment depends on symptoms, age, medical history, prior response, family history, other medications, and patient preference.

2) Monitoring is part of treatment, not a sign of failure

Follow-ups in the first weeks are normal. Clinicians monitor mood changes, sleep shifts, agitation, and suicidal thinking because the early treatment period is when risk can change. Caregivers may also be asked to watch for behavior changes in teens and young adults.

3) Therapy and lifestyle support still matter

Medication is one tool. Psychotherapy, sleep hygiene, exercise, social support, and reducing alcohol/substance use can all matter too. In many cases, combined care is the best path.

4) Public health messaging should reduce harm, not increase it

When leaders talk about antidepressants, precision matters. A clumsy statement can increase stigma, confuse families, and push people away from treatment. That’s not “asking hard questions.” That’s making care harder to access.

What Patients and Families Should Do Right Now

• If you’re taking an antidepressant: Don’t stop suddenly because of a headline.
• If you’re worried about side effects: Contact your doctor or prescriber and describe what changed, when it started, and how severe it is.
• If you’re starting a new antidepressant: Ask about the monitoring plan, expected timeline, and common side effects.
• If your child or teen is starting treatment: Ask what warning signs to watch for in the first few weeks and after dose changes.
• If symptoms worsen quickly or you notice alarming changes: Seek urgent medical support immediately.

And if someone is in immediate emotional crisis or talking about self-harm, contact emergency services or reach out to 988 for crisis support in the U.S. It’s available 24/7.

Bottom Line

RFK Jr.’s comments about antidepressants being dangerous have reignited a debate, but mental health experts are drawing a firm line between real medication risks and unsupported claims. SSRIs are not perfect. They can cause side effects. They carry serious warnings, especially for younger patients. They require careful prescribing and follow-up.

But the evidence-based response is not fear, stigma, or blanket condemnation. It’s informed care, close monitoring, and honest conversations between patients and clinicians.

In other words: antidepressants deserve respectnot mythology.

Experiences From Real-World Care Settings (Composite, Anonymized Examples)

The experiences below are composite examples based on common patterns reported by patients, families, therapists, and prescribers. They are included to reflect real-life situations without identifying any individual person.

A college student who almost quit on day five

A 19-year-old college student started an SSRI for depression and panic symptoms. By day five, she felt more jittery, slept badly, and texted a friend, “This med is making me worse.” Then she saw a viral post claiming antidepressants were dangerous and almost stopped immediately. At her follow-up, her clinician explained that some people feel temporary activation or stomach upset early on, and that the medication often takes several weeks to show mood benefits. They adjusted the dose timing, made a check-in plan, and reviewed warning signs that would require urgent help. Two weeks later, the jitteriness had eased. Six weeks later, she reported fewer panic attacks and better concentration. Her experience is common: the first week can be rough, and the internet usually leaves out the part where monitoring and dose adjustment actually help.

A parent scared by the black box warning

A father whose 15-year-old son was prescribed sertraline read the medication handout and got alarmed by the suicide warning. He worried the medicine itself would “cause” suicidal behavior. The psychiatrist walked him through the warning carefully: the risk is about possible increased suicidal thoughts or behaviors in some younger patients early in treatment, which is exactly why close monitoring is part of care. They set up weekly check-ins, gave the family a short list of changes to watch for (sudden agitation, worsening mood, unusual behavior shifts), and coordinated with the teen’s therapist. The father later said the most helpful part wasn’t reassuranceit was having a concrete plan. Families usually do better when they get clarity instead of vague “don’t worry” language.

An adult who stopped cold turkey after a headline

A 34-year-old man taking escitalopram for anxiety read a sensational news post and quit his medication the same day. Within 48 hours, he had dizziness, nausea, a “brain zap” sensation, and felt emotionally all over the place. He assumed the medication had permanently harmed him, but his doctor recognized discontinuation symptoms and helped him restart and taper safely. He later said he wished someone had told him earlier that stopping suddenly could cause withdrawal-like symptoms. That’s an incredibly common gap: many patients are warned about starting side effects, but not enough are warned about stopping side effects.

A therapy-first patient who later chose combined treatment

A woman in her 40s with depression initially wanted to avoid medication entirely. Her primary care doctor supported that preference and referred her for cognitive behavioral therapy. Therapy helped, but after several months she still had persistent fatigue, early waking, and low mood that interfered with work. She and her clinician revisited the decision and added an antidepressant while continuing therapy. She described the combined approach as “finally getting traction.” This is another real-world pattern experts often point out: treatment decisions can evolve. Choosing medication later doesn’t mean therapy failed, and choosing therapy first doesn’t mean someone is “anti-med.” It means care is individualized.

A patient who needed a different medication, not no medication

One patient developed side effects on his first SSRI and assumed all antidepressants were off the table. After talking with his psychiatrist, he switched medications and tolerated the second option much better. This is a key experience experts emphasize: a bad reaction to one antidepressant does not automatically predict failure with every antidepressant. Medication matching can take time, and that process is frustratingbut it’s normal.

Across all these stories, the theme is the same: the biggest risk often comes from oversimplified messaging. “Antidepressants are dangerous” is too blunt to guide anyone safely. The better message is: antidepressants can help, they can cause side effects, and they should be used with informed consent, follow-up, and a plan.